NoticeMedications

Clinere, Carbamide Peroxide, a) 2 bottles of Clinere Carbamide Peroxide (2 x 0.50 mL) 6.5%, 0.5 fl. oz. (15 mL); b) 1 bo

Manufacturer / Brand: Bell Pharmaceuticals, Inc

Reason for Recall

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Date Issued

Category

Medications

Status

unknown

Issuing Agency

FDA CDER

What to do if you're affected

  • Check the lot number on your medication package against the specific lots listed in the recall notice — not every batch is always affected.
  • Do not stop a prescription medication without first consulting your doctor or pharmacist. Abrupt discontinuation of some drugs carries serious risks.
  • Contact your pharmacy — they can verify whether your dispensed lot is affected and arrange a replacement prescription.
  • For most insurance plans, a replacement fill triggered by a recall is covered even before the normal refill date.
  • Report any adverse effects to the FDA at 1-800-FDA-1088 or through MedWatch at fda.gov/safety/medwatch.

About the FDA CDER

This recall was issued by or conducted in cooperation with the FDA's Center for Drug Evaluation and Research (CDER), which oversees prescription and over-the-counter medications sold in the United States. Drug recalls may be initiated voluntarily by the manufacturer or at FDA's request after a quality problem is identified through manufacturer testing, FDA inspection, or adverse event reports. Recalls are classified by severity: Class I involves products that may cause serious injury or death; Class II and III involve lower levels of risk. Do not stop a prescription medication due to a recall without first consulting your doctor or pharmacist.

View all FDA CDER recalls →

Opens the official government source. Always refer to official sources for the most current information.

Related Recalls

NoticeMedications

BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol), 60 x 1 mL applicators/carton,

CareFusion 213, LLC

Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator

View recall →
NoticeMedications

CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Ch

Chiesi USA, Inc.

Lack of Assurance of Sterility

View recall →
NoticeMedications

Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;

Cipla USA, Inc.

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

View recall →